We describe a patient with therapy-resistant cutaneous T-cell lymphoma, Sézary syndrome
variant, in association with concurrent polyarthritis and vitiligo, who was successfully treated …

Sézary syndrome, an aggressive form of cutaneous T-cell lymphoma, is a devastating,
highly symptomatic form of non-Hodgkin lymphoma. Malignant clones of mature helper CD4 …

Extracorporeal photopheresis is generally accepted as standard therapy for the leukaemic
and erythrodermic variant of cutaneous T‐cell lymphoma, the Sézary syndrome (SS) …

Background: Extracorporeal photopheresis (ECP) is recommended for the treatment of
Sézary syndrome (SS), the leukemic variant of cutaneous T‐cell lymphoma (CTCL). Several …

Background Several retrospective studies have claimed that extracorporeal photopheresis
(ECP) prolongs survival in patients with erythrodermic cutaneous T-cell lymphoma. In a …

Background: Extracorporeal photopheresis (ECP) has become a primary therapy for
selected forms of cutaneous T-cell lymphoma, especially Sézary syndrome. Variability in …

Background: The beneficial effect of extracorporeal photochemotherapy has clearly been
established for patients with cutaneous T-cell lymphoma with Sézary's syndrome. But this …

We describe a 53-year-old HIV-negative white man who had chronic CD4+ T
lymphocytopenia and photoaccentuated erythroderma with lymphoma-like histologic …

Sézary syndrome is a form of leukemia-lymphoma characterized clinically by erythroderma,
pruritus, adenopathy, and circulating atypical cells with cerebriform nuclei. Histologically …

To the Editor: Photopheresis has been proposed as standard treatment for advanced stages
of cutaneous T-cell lymphoma (CTCL), and the identification of prognostic variables …